David H. Deming serves as Executive at ALBANY MOLECULAR RESEARCH INC, where they oversee executive responsibilities. Since joining the company, David H. Deming has executed 14 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 23,800 shares valued at $0.
David H. Deming currently holds 37,800 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David H. Deming has been a net neutral trader of AMRI stock. They have purchased $0 and sold $0 worth of shares.
David H. Deming's most recent insider trade was on Feb 5, 2026, when they sold 23,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 28, 2024 | BFYW | $0 | Award | 75,000 | $N/A | Discretionary |
| Jul 18, 2023 | BFYW | $0 | Award | 5,270,271 | $N/A | Discretionary |
| Jun 2, 2023 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Mar 29, 2023 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Dec 1, 2022 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Sep 1, 2022 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Jul 12, 2022 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Apr 12, 2022 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Jan 3, 2022 | BFYW | $0 | Award | 25,000 | $N/A | Discretionary |
| Dec 14, 2021 | BFYW | $48.4K | Award | 403,747 | $0.12 | Discretionary |
| Aug 31, 2017 | AMRI | $148.7K | Disposition | 6,838 | $21.75 | Discretionary |
| Jun 15, 2016 | AMRI | $45.0K | Award | 3,036 | $14.82 | Discretionary |